Interv Akut Kardiol. 2007;6(5):203-204
More and more aggressive antiplatelet treatment can decrease the prevalence of ischemic complications of atherosclerosis however at the cost of an increase of serious bleeding complications. Study TRITON-TIMI 38 confiremd the reality for prasugrel, but in he same time it showed an exceptioal efficacy of hte medications in decreasing of stent thrombosis. The selection of patient groups with increased risk of bleeding is the greatest contribution of the study and enables much more effective use of the medication in every day clinical practice.
Published: January 16, 2008 Show citation
Go to original source...
Go to PubMed...